Porriño-Bustamante María Librada, Fernández-Pugnaire María Antonia, Arias-Santiago Salvador
Dermatology Department, University Hospital La Zarzuela, 28023 Madrid, Spain.
Dermatology Department, University of Granada, 18016 Granada, Spain.
J Clin Med. 2021 Apr 21;10(9):1805. doi: 10.3390/jcm10091805.
Frontal fibrosing alopecia is a scarring alopecia, the prevalence of which is increasing worldwide since its first description in 1994. The reason for this emerging epidemic may be a higher exposure to an unknown trigger, although its aethiology and pathogenesis still remain enigmatic. Clinical, trichoscopic, sonographic, and histopathologic findings are allowing clinicians to understand more aspects about this type of cicatricial alopecia. Several treatments have been used in frontal fibrosing alopecia, although the 5-alpha reductase inhibitors seem to be the most promising. The aim of this report is to provide a compilation about the published data regarding frontal fibrosing alopecia in a narrative review.
额部纤维性秃发是一种瘢痕性秃发,自1994年首次被描述以来,其在全球的患病率一直在上升。这种新出现的流行疾病的原因可能是接触了一种未知触发因素的机会增加,尽管其病因和发病机制仍然不明。临床、毛发镜、超声和组织病理学检查结果使临床医生能够更多地了解这种瘢痕性秃发。额部纤维性秃发已采用多种治疗方法,尽管5-α还原酶抑制剂似乎最有前景。本报告的目的是在一篇叙述性综述中汇总已发表的有关额部纤维性秃发的数据。